Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: INDOMETHACIN — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves a supplemental application for Indomethacin from Amneal Pharmaceuticals LLC (ANDA 091549), authorizing a supplemental change to the generic product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INDOMETHACIN (INDOMETHACIN)

Snippet

SUPPL AP for INDOMETHACIN (INDOMETHACIN)